# Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

> **NCT00850239** · PHASE3 · TERMINATED · sponsor: **Phenomix** · enrollment: 700 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** dutogliptin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00850239
- **Lead sponsor:** Phenomix
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-05
- **Primary completion:** 2010-10
- **Final completion:** 2010-12
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2010-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00850239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00850239, "Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00850239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*